Allurion stock surges 70% on weight-loss therapy update (Alur: NYSE)


Obesity card in doctor's hands

Mikhail_petrov-96

Allurion shares (NYSE:channel) surged 70% in after-market trading Thursday after ending the regular session up 21% on news that the company plans to conduct a clinical study of its gastric balloon weight loss product in combination with LPG drugs -1.

Allurion (



Source link

  • Related Posts

    Wall Street will stymie Donald on US Oil Surge Plan, Bosses say

    Donald Trump’s call for a new Boom Boom will be thwarted by Wall Street’s refusal to approve another drilling binge, shale bosses have warned. Total US wool The output of…

    Economic Calendar on Friday

    Economic Calendar on Friday Source link

    Leave a Reply

    Your email address will not be published. Required fields are marked *